Amendment #1 to the Evaluation Corporation AgreementEvaluation Corporation Agreement • April 18th, 2011 • Accelr8 Technology Corp • Laboratory analytical instruments
Incorporating the terms and conditions of the Evaluation Agreement, effective as of June 14, 2010 (hereinafter collectively referred to as the “Agreement"), made by and between Novartis Vaccines and Diagnostics, Inc. ("Novartis V&D") and Accelr8 Technology Corporation ("Accelr8”), the Agreement is amended, effective as of November 10, 2010 as set forth herein.
Amendment #1 to the Letter of IntentLetter of Intent • April 18th, 2011 • Accelr8 Technology Corp • Laboratory analytical instruments
Incorporating the terms and conditions of the Letter of Intent Agreement, effective as of June 14, 2010 (hereinafter collectively referred to as the "Agreement"), made by and between Novartis Vaccines and Diagnostics Inc. ("Novartis V&D") and Accelr8 Technology Corporation ("Accelr8"), the Agreement is amended, effective as of November 10, 2010, as set forth herein.
